Status:
COMPLETED
Feasibility of Remote Exercise Training for Hispanics/Latinos With MS
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate the potential benefits of a specially designed exercise program for Hispanics/Latinos with multiple sclerosis (MS). The main questions it aims to answ...
Detailed Description
The FERLA MS study is a randomized controlled trial aimed at investigating the feasibility and effectiveness of a remotely-delivered exercise training intervention for Hispanics/Latinos with MS. This ...
Eligibility Criteria
Inclusion
- Age between 18-65 years
- Diagnosis of MS
- Relapse-free for at least 30 days
- Able to walk with or without an assistive device
- Insufficient physical activity (i.e., not meeting current physical activity guidelines of 150 minutes of moderate to vigorous physical activity per week)
- Willingness to complete all required testing procedures, outcome questionnaires, and randomization
- Identify as Hispanic/Latino
- Able to speak, read, and understand English
- Currently reside in Chicago
- Access to the internet and email
- Safe for exercise based on the Physical Activity Readiness Questionnaire (PAR-Q)
Exclusion
- Not between 18-65 years
- No diagnosis of MS
- Not relapse-free for at least 30 days
- Not able to walk with or without an assistive device
- Too much physical activity (i.e. 150 minutes or more of moderate to vigorous physical activity per week)
- Not willing to complete all required testing procedures, outcome questionnaires, and randomization
- Do not identify as Hispanic/Latino
- Unable to speak, read, and understand English
- Not currently residing in Chicago
- No access to the internet and email
- Not safe for exercise based on the PAR-Q
Key Trial Info
Start Date :
April 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT05998616
Start Date
April 27 2024
End Date
December 31 2025
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612